Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Replimune Group, Inc. Director's Dealing 2021

Dec 4, 2021

33193_dirs_2021-12-03_c52ff6a9-969e-49d7-90a8-c884387c2e42.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2021-12-01

Reporting Person: Oliger Christy J. (Director)

More from Replimune Group, Inc.

Regulatory Filings 2026
May 29
Director's Dealing 2026
Feb 20
Major Shareholding Notification 2026
Feb 17
Capital/Financing Update 2026
Feb 3
Interim / Quarterly Report 2026
Feb 3
Investor Presentation 2026
Jan 12
Director's Dealing 2025
Dec 19
Director's Dealing 2025
Dec 19
Director's Dealing 2025
Dec 19
Director's Dealing 2025
Dec 19
View all filings →